Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer

[1]  R. Greil,et al.  Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  V. Vance,et al.  Weight gain in breast cancer survivors: prevalence, pattern and health consequences , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[3]  Jack Cuzick,et al.  Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. , 2010, The Lancet. Oncology.

[4]  C. Leemans,et al.  Radiotherapy on the neck nodes predicts severe weight loss in patients with early stage laryngeal cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  J. Chang-Claude,et al.  Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis , 2010, Breast Cancer Research and Treatment.

[6]  J. Cuzick,et al.  Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Fortin,et al.  Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer , 2010, Cancer.

[8]  P. Bachmann,et al.  Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study. , 2010, Clinical nutrition.

[9]  W. Willett,et al.  Body Mass Index Before and After Breast Cancer Diagnosis: Associations with All-Cause, Breast Cancer, and Cardiovascular Disease Mortality , 2009, Cancer Epidemiology Biomarkers & Prevention.

[10]  F. Johnson,et al.  Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agents , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[11]  J. Fricker.  San Antonio Breast Cancer Symposium. , 2009, The Lancet. Oncology.

[12]  J. Cuzick.  IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole , 2008, Expert review of anticancer therapy.

[13]  B. Sternfeld,et al.  Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer , 2008, Cancer Causes & Control.

[14]  L. Fallowfield.  There's many a slip twixt cup and lip: adherence issues in cancer therapy , 2008, Nature Clinical Practice Oncology.

[15]  Jack Cuzick,et al.  Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. , 2008, The Lancet. Oncology.

[16]  T. Powles,et al.  Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. , 2007, Journal of the National Cancer Institute.

[17]  C. Rock,et al.  Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women’s healthy eating and living (WHEL) study , 2007, Breast Cancer Research and Treatment.

[18]  A. Carmichael,et al.  Obesity and prognosis of breast cancer , 2006, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[19]  G. Francini,et al.  Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids , 2006, British Journal of Cancer.

[20]  M. Mottolese,et al.  New aromatase inhibitors as second‐line endocrine therapy in postmenopausal patients with metastatic breast carcinoma , 2005, Cancer.

[21]  M. Harvie,et al.  Need for Weight Management among Postmenopausal Early Breast Cancer Patients Receiving Adjuvant Endocrine Therapy , 2005, Women's health.

[22]  B. Rosner,et al.  Weight, weight gain, and survival after breast cancer diagnosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Baumgartner,et al.  Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M Baum,et al.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer , 2005, The Lancet.

[25]  N. Boyd,et al.  Weight gain in women with localized breast cancer — a descriptive study , 1988, Breast Cancer Research and Treatment.

[26]  Sue Ashley,et al.  Weight gain after primary surgery for breast cancer - effect of tamoxifen , 2005, Breast Cancer Research and Treatment.

[27]  A. Howell,et al.  Energy Balance in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy , 2004, Breast Cancer Research and Treatment.

[28]  P. Goodwin,et al.  Multidisciplinary weight management in locoregional breast cancer: results of a phase II study , 1998, Breast Cancer Research and Treatment.

[29]  G. Lyman,et al.  Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact? , 1997, Breast Cancer Research and Treatment.

[30]  M. Dowsett.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses , 2003 .

[31]  J. Cuzick,et al.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer , 2003, Cancer.

[32]  M Baum,et al.  First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial , 2002, The Lancet.

[33]  J. Cuzick,et al.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial , 2002, The Lancet.

[34]  J. Myers,et al.  Predictors of Weight Loss During Radiation Therapy , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[35]  S. Kulkarni,et al.  Pharmacodynamics of drug-induced weight gain. , 2001, Drugs of today.

[36]  J. Costantino,et al.  Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  P. Goodwin,et al.  Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  T. Powles,et al.  Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial , 1998, The Lancet.

[39]  B. Guy-grand,et al.  Weight gain at the time of menopause. , 1997, Human reproduction.

[40]  B Fisher,et al.  Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. , 1996, Journal of the National Cancer Institute.

[41]  C. Christiansen,et al.  Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. , 1995, Metabolism: clinical and experimental.

[42]  L. Nail,et al.  Fatigue and the cancer experience: the state of the knowledge. , 1994, Oncology nursing forum.

[43]  L. Sachs,et al.  Nutritional concerns of women with breast cancer. , 1993, Journal of cancer education : the official journal of the American Association for Cancer Education.

[44]  R. Wing.  Obesity and weight gain during adulthood: a health problem for United States women. , 1992, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[45]  J. Carpenter,et al.  Weight gain with breast cancer adjuvant treatment , 1991, Cancer.

[46]  B. Rolls,et al.  Weight gain in patients with breast cancer receiving adjuvant treatment as a function of restraint, disinhibition, and hunger. , 1990, Oncology nursing forum.

[47]  M. Knobf.  Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.